BioSpace News Archive

Deals

Dialyze Direct to Acquire Affiliated Dialysis Centers

Acquisition would position Dialyze Direct as the largest provider of on-site home hemodialysis in nursing homes in the U.S.

September 5, 2018
·
4 min read
Policy

Antidote Therapeutics Receives Orphan Drug Designation for ATI-1013 for the Treatment of Buerger’s Disease

Human anti-nicotine monoclonal antibody under development offers potential to reduce symptoms and block or slow disease progression of this rare disease.

September 5, 2018
·
3 min read
Business

Dow Develops Leaders While Addressing World Challenges

Through Sixth-Annual Leadership in Action Program, Dow Deploys 43 Employees to India to Address Pressing Local Challenges

September 5, 2018
·
6 min read
Business

Secarna Pharmaceuticals and Firebrand Therapeutics enter into co-development agreement for novel cancer therapies

Secarna’s proprietary antisense oligonucleotide platform LNAplusTM to be combined with Firebrand Therapeutics’ scientifically leading research into mechanisms of cancer metastasis.

September 5, 2018
·
3 min read
Motif Bio plc (AIM/NASDAQ: MTFB) - Motif Bio Presents Iclaprim Data at ESCMID/ASM Conference

Iclaprim overview presented in State of the Art Lecture.

September 5, 2018
·
9 min read
Global Diabetic Macular Edema Treatment Market 2018-2022| Use of New Laser Delivery Systems to Boost Demand| Technavio

The global diabetic macular edema treatment market 2018-2022 is expected to post a CAGR of more than 1% during the forecast period, according to the latest market research report by Technavio.

September 5, 2018
·
4 min read
Lone Star Bio

Wipe Out Kids’ Cancer Oktoberfest 5K and Family Fun Run on September 22, 2018

The Town of Addison Welcomes Families, Teams and Supporters to Join the Fight Against Pediatric Cancer

September 5, 2018
·
3 min read
Drug Development

Spectrum Pharmaceuticals Announces Release of Poziotinib Abstract as Part of the IASLC 19th World Conference on Lung Cancer

The abstract reported new interim data from the EGFR cohort and, for the first time, the HER2 cohort in the MD Anderson Phase 2 trial

September 5, 2018
·
10 min read
Drug Development

MabSpace Biosciences Doses First Patient in China Phase 1 Trial for MSB2311 and Submitted IND for MSB0254 to NMPA

MabSpace Biosciences announced that on August 24th, 2018, MSB2311 was successfully administered to the first Chinese cancer patient at Beijing Cancer Hospital in its China Phase 1 trial.

September 5, 2018
·
3 min read
Drug Development

Baloxavir Marboxil Phase II and III Studies for the Treatment of Influenza Published in the New England Journal of Medicine

Shionogi & Co., Ltd. today announced the positive results from Phase II and III studies of baloxavir marboxil for the treatment of influenza in otherwise-healthy patients have been published in the New England Journal of Medicine (NEJM) in the September 6, 2018 issue.

September 5, 2018
·
9 min read